Skip to main content
Erschienen in: Archives of Dermatological Research 10/2016

28.09.2016 | Original Paper

Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts

Erschienen in: Archives of Dermatological Research | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Nephrogenic systemic fibrosis (NSF) is a disease characterized by fibrosis of the systemic organs in patients with renal failure. Following the findings of recent epidemiological studies and the finding of gadolinium (Gd) in the skin tissue of NSF patients, it is now definitely known that the use of Gd contrast agents can trigger NSF. To date, however, the exact mechanism underlying the induction of fibrosis in various organs by Gd remains unexplained. This study was undertaken to evaluate the influence of Gd on the proliferation activity and collagen production of cultured fibroblasts. Normal human dermis-derived fibroblasts were incubated in the presence of gadodiamide (GA) in the concentration range of 5 × 10−7 to 5 × 10−3 M. The proliferation activity of the cells was assessed on the basis of the cell counts in the fibroblast growth curve and the DNA-synthetic activity of the cells (indicator; level of 3H-thymidine uptake by cells). The collagen production was evaluated by densitometric measurement of the quantity of collagen through electrophoresis and fluorography after incorporation of 3H-proline into the procollagens. Furthermore, the expression levels of the genes for type I and III collagen were measured by real-time reverse transcription polymerase chain reaction (RT-PCR) assay. The cell count tended to be higher when the fibroblasts were incubated in medium containing GA in the concentration range of 5 × 10−7 to 5 × 10−4M as compared to that in the GA-free control cultures; furthermore, the DNA-synthetic activity also rose in a concentration-dependent manner in the GA-treated group as compared to that in the control group. No significant changes in either the collagen production or the collagen gene expression levels were noted in cultures containing GA at concentrations between 5 × 10−7 and 5 × 10−3 M. These results suggest that the formation of sclerosing lesions in patients with NSF may be attributable to the effect of GA of enhancing the growth activity of fibroblasts.
Literatur
1.
Zurück zum Zitat Brazova L, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A (2006) Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 121:350–357CrossRefPubMed Brazova L, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A (2006) Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 121:350–357CrossRefPubMed
2.
Zurück zum Zitat Broome DR (2008) Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66:230–234CrossRefPubMed Broome DR (2008) Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66:230–234CrossRefPubMed
3.
Zurück zum Zitat Bujor MA, Pannu J, Bu S, Smith AE, Muise-Helmericks CR, Trojanowska M (2008) Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 128:1906–1914CrossRefPubMed Bujor MA, Pannu J, Bu S, Smith AE, Muise-Helmericks CR, Trojanowska M (2008) Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 128:1906–1914CrossRefPubMed
4.
Zurück zum Zitat Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001CrossRefPubMed Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001CrossRefPubMed
5.
Zurück zum Zitat Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O’Brien PE (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39:967–971CrossRefPubMed Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O’Brien PE (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39:967–971CrossRefPubMed
6.
7.
Zurück zum Zitat Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD (2008) Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214:584–593CrossRefPubMed Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD (2008) Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214:584–593CrossRefPubMed
8.
Zurück zum Zitat Fleischmajer R, Perlish JS, Krieg T, Timpl R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403CrossRefPubMed Fleischmajer R, Perlish JS, Krieg T, Timpl R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403CrossRefPubMed
9.
Zurück zum Zitat Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316:83–94CrossRefPubMed Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316:83–94CrossRefPubMed
10.
Zurück zum Zitat Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2 (I) collagen genes in a patient with a pro alpha 2 (I)–chain–defective variant of Ehlers-Danlos syndrome. Eur J Biochem 174:231–237CrossRefPubMed Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2 (I) collagen genes in a patient with a pro alpha 2 (I)–chain–defective variant of Ehlers-Danlos syndrome. Eur J Biochem 174:231–237CrossRefPubMed
11.
Zurück zum Zitat Hatamochi A, Arakawa M, Takeda K, Ueki H (1994) Activation of fibroblast proliferation by Werner’s syndrome fibroblast-conditioned medium. J Dermatol Sci 7:210–216CrossRefPubMed Hatamochi A, Arakawa M, Takeda K, Ueki H (1994) Activation of fibroblast proliferation by Werner’s syndrome fibroblast-conditioned medium. J Dermatol Sci 7:210–216CrossRefPubMed
12.
Zurück zum Zitat Hayashi S, Ikeda M, Kitamura Y, Hamasaki Y, Hatamochi A (2012) UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. J Dermatol Sci 67:20–25CrossRefPubMed Hayashi S, Ikeda M, Kitamura Y, Hamasaki Y, Hatamochi A (2012) UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. J Dermatol Sci 67:20–25CrossRefPubMed
13.
Zurück zum Zitat Helmig S, Belwe A, Schneider J (2009) Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. J Investig Med 57:655–661CrossRefPubMed Helmig S, Belwe A, Schneider J (2009) Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. J Investig Med 57:655–661CrossRefPubMed
14.
Zurück zum Zitat High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2006) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26CrossRefPubMed High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2006) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26CrossRefPubMed
15.
Zurück zum Zitat Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50:2660–2666CrossRefPubMed Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50:2660–2666CrossRefPubMed
16.
Zurück zum Zitat Kay J (2008) Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction. Ann Rheum Dis 67(suppl 3):66–69 Kay J (2008) Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction. Ann Rheum Dis 67(suppl 3):66–69
17.
Zurück zum Zitat Koreishi AF, Nazarian RM, Saenz AJ, Klepeis VE, McDonald AG, Farris AB, Colvin RB, Duncan LM, Mandal RV, Kay J (2009) Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med 133:1943–1948PubMed Koreishi AF, Nazarian RM, Saenz AJ, Klepeis VE, McDonald AG, Farris AB, Colvin RB, Duncan LM, Mandal RV, Kay J (2009) Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med 133:1943–1948PubMed
18.
Zurück zum Zitat Le LP, Garibyan L, Lara D, Finberg KE, Lafrate AJ, Duncan LM, Kay J, Nazarian RM (2013) Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis. Am J Dermatopathol 35:351–356CrossRefPubMed Le LP, Garibyan L, Lara D, Finberg KE, Lafrate AJ, Duncan LM, Kay J, Nazarian RM (2013) Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis. Am J Dermatopathol 35:351–356CrossRefPubMed
19.
Zurück zum Zitat Morcos SK, Thomsen HS (2008) Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 110:24–31CrossRef Morcos SK, Thomsen HS (2008) Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 110:24–31CrossRef
20.
Zurück zum Zitat Namikawa H, Sunazuka T, Kitamura Y, Suzuki T, Hamasaki Y, Yamazaki S, Omura S, Hatamochi A (2010) Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. Arch Dermatol Res 302:341–348CrossRefPubMed Namikawa H, Sunazuka T, Kitamura Y, Suzuki T, Hamasaki Y, Yamazaki S, Omura S, Hatamochi A (2010) Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. Arch Dermatol Res 302:341–348CrossRefPubMed
21.
Zurück zum Zitat Quatresooz P, Paquet P, Hermanns-Lê T, Piérard GE (2010) Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis. Appl Immunohistochem Mol Morphol 18:448–452PubMed Quatresooz P, Paquet P, Hermanns-Lê T, Piérard GE (2010) Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis. Appl Immunohistochem Mol Morphol 18:448–452PubMed
22.
Zurück zum Zitat Reyes-Gordillo K, Shah R, Arellanes-Robledo J, Hemandez-Nazara Z, Rincon-Sanchez RA, Inagaki Y, Rojkind M, Raj Lakshman M (2014) Mechanisms of action of acetaldehyde in the Up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. Am J Pathol 184:1458–1467CrossRefPubMedPubMedCentral Reyes-Gordillo K, Shah R, Arellanes-Robledo J, Hemandez-Nazara Z, Rincon-Sanchez RA, Inagaki Y, Rojkind M, Raj Lakshman M (2014) Mechanisms of action of acetaldehyde in the Up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. Am J Pathol 184:1458–1467CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, Roberts A (1999) Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol 154:1115–1124CrossRefPubMedPubMedCentral Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, Roberts A (1999) Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol 154:1115–1124CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Todd DJ, Kagan A, Chibnik LB, Kay J (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441CrossRefPubMed Todd DJ, Kagan A, Chibnik LB, Kay J (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441CrossRefPubMed
25.
Zurück zum Zitat Wagner B, Tan C, Barnes JL, Ahuja S, Davis TL, Gorin Y, Jimenez F (2012) Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181:1941–1952CrossRefPubMed Wagner B, Tan C, Barnes JL, Ahuja S, Davis TL, Gorin Y, Jimenez F (2012) Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181:1941–1952CrossRefPubMed
Metadaten
Titel
Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts
Publikationsdatum
28.09.2016
Erschienen in
Archives of Dermatological Research / Ausgabe 10/2016
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1689-9

Weitere Artikel der Ausgabe 10/2016

Archives of Dermatological Research 10/2016 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.